© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
Oncology
FDA Approves New Combo Breast Cancer Treatment for Subcutaneous Injection
July 01, 2020
The fixed-dose combination of pertuzumab and trastuzumab with hyaluronidase (Phesgo; Genentech) can be administered subcutaneously for patients with HER2-positive breast cancer.
Pharmacists: Fight Racial Disparities in Health Care
June 26, 2020
Today, pharmacists are banding together to “eliminate racism, discrimination, injustice, and the marginalization of individuals within the profession.”
Ribociclib Shows Overall Survival Benefit in Patients With Advanced Breast Cancer With Visceral Metastases
June 11, 2020
An exploratory analysis of 2 phase 3 trials evaluating ribociclib (Kisqali, Novartis) plus endocrine therapy in advanced breast cancer showed positive results.
Survey: Oncology Pharmacists Report Impaired Access to PPE, Certain Medications
June 10, 2020
Oncology pharmacy practitioners highlight challenges amid the pandemic, such as limited access to personal protective equipment and essential medications.
Cabozantinib With Nivolumab Extended PFS in Patients With Advanced Recurring Endometrial Cancer
June 08, 2020
The study, presented at the virtual ASCO20, showed significant clinical benefit for patients with endometrial cancer who were treated with cabozantinib and nivolumab.
FDA OKs Atezolizumab Plus Bevacizumab for Frontline Treatment of Advanced Liver Cancer
June 01, 2020
Officials with the FDA approved atezolizumab (Tecentriq, Genentech) in combination with bevacizumab (Avastin) for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.
Systematic Review Evaluates Cannabis, Cannabinoids in Palliative and Supportive Oncology Care
May 30, 2020
A systematic review of medical cannabis and cannabinoid use in oncology care demonstrated varied results.
Adjuvant Osimertinib Therapy Delays Disease Recurrence in Localized NSCLC
May 30, 2020
Targeted therapy osimertinib (Tagrisso) demonstrated significant improvements in disease-free survival in patients with localized non-small cell lung cancer (NSCLC) who were treated following surgery.
ASCO20 Virtual: Pembrolizumab Doubles Progression-Free Survival for Certain Advanced Colorectal Cancer Types
May 29, 2020
The study marks the first time that the drug has demonstrated benefit for front-line therapy in patients with this type of colorectal cancer.
Study: Inclusion of Oncology Pharmacist Led to Financial, Clinical Benefits in Clinic
May 29, 2020
An outpatient multiple myeloma clinic benefited substantially from employing a clinical pharmacist.